The purpose of this guidance from EGPAF is to aid health care workers and support caregivers and children initiated on, or switched to, pDTG-based ART to ensure that:
the pDTG is being administered in the correct dosage and frequency;
health care workers and caregivers check for adverse drug reactions and signs of intolerance; and
follow-up is performed for scheduled clinical and ART pickup visits.
The algorithm should be adapted to the country-specific context, policies, and guidelines, specifically to align with a country’s multi-month dispensing (MMD) and viral load testing schedules. Most countries currently allow MMD, mostly for children greater than 2 years old.